Shabana Mohammad Ali. “Safety of Dapagliflozinin Reducing Cardiac Events and Deaths Among NYHA Class II and III Cardiac Failure Patients”. Pakistan Journal of Medical & Health Sciences 18, no. 01 (April 19, 2024): 35. Accessed September 1, 2024. https://pjmhsonline.com/index.php/pjmhs/article/view/5440.